# Clinical Study of the Effectiveness, Tolerability and Safety of the Drug "Anti-spike, Gel, 100 g in Bottles in Package No. 1" Produced by the Republican Unitary Enterprise "Unitekhprom BSU", With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis

> **NCT06365632** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Research Institute for Physical Chemical Problems of the Belarusian State University** · enrollment: 100 (estimated)

## Conditions studied

- Abdominal Adhesions

## Interventions

- **DRUG:** Antispike gel, 100 g in a flask, produced by UNITEHPROM BSU, Republic of Belarus
- **PROCEDURE:** antegrade appendectomy

## Key facts

- **NCT ID:** NCT06365632
- **Lead sponsor:** Research Institute for Physical Chemical Problems of the Belarusian State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-19
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06365632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06365632, "Clinical Study of the Effectiveness, Tolerability and Safety of the Drug "Anti-spike, Gel, 100 g in Bottles in Package No. 1" Produced by the Republican Unitary Enterprise "Unitekhprom BSU", With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06365632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*